Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) P/E ratio
As of 6 November 2026, Progyny, Inc. (PGNY) trades at a P/E ratio of 30.1×. Over the past ten years it has ranged from 0.0× (September 2020) to 1,567× (December 2020); the current reading is higher than 26% of that period. That is above the Healthcare Plans industry median of 22.5× and above the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 37.2× | 29.45% |
| FY2024 | 28.8× | (49.01%) |
| FY2023 | 56.4× | (39.18%) |
| FY2022 | 92.7× | 36.24% |
| FY2021 | 68.0× | (12.12%) |
| FY2020 | 77.4× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 21.8× | (26.58%) |
| Jun 2026 | 29.7× | 41.78% |
| Mar 2026 | 21.0× | (43.67%) |
| Dec 2025 | 37.2× | 14.14% |
| 28 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| OSCR Oscar Health, Inc. compare | 11.0× |
| CI Cigna Group compare | 12.9× |
| ELV Elevance Health, Inc. compare | 18.2× |
| CNC Centene Corporation compare | 23.5× |
| PGNY Progyny, Inc. | 30.1× |
| HUM Humana Inc. compare | 41.9× |
| ALHC Alignment Healthcare, Inc. compare | 48.4× |
| Healthcare Plans industry median | 22.5× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement